RCT | Effects of prostate cancer screening with PSA and MRI followed by targeted biopsy only.
9 Dec, 2022 | 13:32h | UTCProstate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only – New England Journal of Medicine (link to abstract – $ for full-text)
News Release: New prostate cancer diagnostic pathway paves way for general screening – University of Gothenburg
Commentary: MRI-Targeted Biopsy Beneficial for Men With Elevated PSA – HealthDay
Commentary on Twitter
In a prostate-cancer screening trial involving men with lesions shown on MRI, targeted biopsy alone detected half as many clinically insignificant tumors as targeted and systematic biopsy, with few significant tumors missed. https://t.co/1H6pRN4aLR pic.twitter.com/yy3PAtYuZK
— NEJM (@NEJM) December 8, 2022